<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02044978</url>
  </required_header>
  <id_info>
    <org_study_id>Tandskruv tidsserie</org_study_id>
    <nct_id>NCT02044978</nct_id>
  </id_info>
  <brief_title>Initial Fixation of Bisphosphonate-coated Dental Implants</brief_title>
  <official_title>Initial Fixation of Bisphosphonate-coated Dental Implants</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Per Aspenberg</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Linkoeping</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      16 patients will be included. Each patient receives 2 dental implants. One of them is coated
      with a drug, zoledronate, to improve fixation. Fixation is measured by vibration resonance
      frequency analysis at insertion and 2, 4, 6 and 8 weeks after insertion.The 2 implants in
      each patient are compared. We expect to find an early improvement (higher resonance
      frequency) in the coated implant.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The zoledronate is linked to the titanium implant surface via a nanolayer of crosslinked
      fibrinigen. Resonance frequency is measured with standard clinical equipment (Ostell
      apparatus).
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2014</start_date>
  <completion_date type="Anticipated">January 2017</completion_date>
  <primary_completion_date type="Anticipated">January 2016</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Vibration frequency ratio</measure>
    <time_frame>4 and 6 weeks</time_frame>
    <description>Each patients has a study implant and a control implant. Their change vibation frequency from insertion till measurement time point is measured and the ratio between changes for the 2 implants forms the outcome measure. Avarage values for 4 and 6 weeks will be used.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Marginal resorption</measure>
    <time_frame>8 weeks</time_frame>
    <description>Radiographic loss of bone at the margin of the implant, measured as difference in mm from the superficial bone contour between insertion and 8 weeks.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vibration: area under the curve</measure>
    <time_frame>2-8 weeks</time_frame>
    <description>Each patients has a study implant and a control implant. Their change vibation frequency from insertion till measurement time point is measured and the ratio between changes for the 2 implants forms the outcome measure. Avarage values for all weeks will be used.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">16</enrollment>
  <condition>Pre-integration Failure of Dental Implant</condition>
  <arm_group>
    <arm_group_label>Bisphosphonate implant</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Dental implant coated with zoledronate Note: Both arms in each patient (2 implants)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Dental implant without coating Note: Both arms in each patient (2 implants)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Zoledronate-coated dental implant</intervention_name>
    <arm_group_label>Bisphosphonate implant</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Need for dental implant in upper jaw. CTscan showing at least 6 mm bucco-lingual thickness.
        Generally healthy

        Exclusion Criteria:

        Drugs or conditions that influence or are thought to influence bone healing, such as
        bisphosphonates, corticosteroids, other oral pathologies, severe autoimmune diseases,
        cancer. Osteoporosis is not cause for exclusion.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jahan Abtahi, MD, PhD</last_name>
    <email>jahan.abtahi@lio.se</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Per Aspenberg, MD, PhD</last_name>
    <email>per.aspenberg@liu.se</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Käkcentralen</name>
      <address>
        <city>Linköping</city>
        <zip>58185</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jahan Abtahi, MD PhD</last_name>
      <email>jahan.abtahi@lio.se</email>
    </contact>
    <investigator>
      <last_name>Jahan Abtahi, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tandläkarhuset</name>
      <address>
        <city>Linköping</city>
        <zip>58227</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jahan Abtahi, MD PhD</last_name>
      <email>jahan.abtahi@lio.se</email>
    </contact>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>June 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 22, 2014</study_first_submitted>
  <study_first_submitted_qc>January 22, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 24, 2014</study_first_posted>
  <last_update_submitted>June 8, 2015</last_update_submitted>
  <last_update_submitted_qc>June 8, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 9, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Linkoeping</investigator_affiliation>
    <investigator_full_name>Per Aspenberg</investigator_full_name>
    <investigator_title>professor</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Zoledronic acid</mesh_term>
    <mesh_term>Diphosphonates</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

